[DPHARMA] QoQ Quarter Result on 30-Sep-2023 [#3]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
08-Nov-2023
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2023
Quarter
30-Sep-2023 [#3]
Profit Trend
QoQ- -28.47%
YoY- -45.13%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Quarter Result
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Revenue 218,324 192,968 167,501 169,235 167,516 200,475 151,960 27.35%
PBT 21,960 20,101 7,034 11,427 16,515 28,292 15,347 27.00%
Tax -5,271 -4,824 1,468 -2,457 -3,974 -5,659 1,814 -
NP 16,689 15,277 8,502 8,970 12,541 22,633 17,161 -1.84%
-
NP to SH 16,689 15,277 8,502 8,970 12,541 22,633 17,161 -1.84%
-
Tax Rate 24.00% 24.00% -20.87% 21.50% 24.06% 20.00% -11.82% -
Total Cost 201,635 177,691 158,999 160,265 154,975 177,842 134,799 30.82%
-
Net Worth 692,598 682,979 682,979 673,359 670,448 666,567 657,045 3.57%
Dividend
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Div 9,619 - 17,314 - 4,788 - 17,140 -31.98%
Div Payout % 57.64% - 203.66% - 38.19% - 99.88% -
Equity
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Net Worth 692,598 682,979 682,979 673,359 670,448 666,567 657,045 3.57%
NOSH 961,942 961,942 961,942 961,942 961,942 952,239 952,239 0.67%
Ratio Analysis
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
NP Margin 7.64% 7.92% 5.08% 5.30% 7.49% 11.29% 11.29% -
ROE 2.41% 2.24% 1.24% 1.33% 1.87% 3.40% 2.61% -
Per Share
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
RPS 22.70 20.06 17.41 17.59 17.49 21.05 15.96 26.49%
EPS 1.73 1.59 0.88 0.93 1.31 2.38 1.80 -2.61%
DPS 1.00 0.00 1.80 0.00 0.50 0.00 1.80 -32.44%
NAPS 0.72 0.71 0.71 0.70 0.70 0.70 0.69 2.88%
Adjusted Per Share Value based on latest NOSH - 961,942
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
RPS 22.68 20.05 17.40 17.58 17.40 20.83 15.79 27.33%
EPS 1.73 1.59 0.88 0.93 1.30 2.35 1.78 -1.88%
DPS 1.00 0.00 1.80 0.00 0.50 0.00 1.78 -31.93%
NAPS 0.7195 0.7095 0.7095 0.6995 0.6965 0.6924 0.6825 3.58%
Price Multiplier on Financial Quarter End Date
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Date 28/06/24 29/03/24 29/12/23 29/09/23 30/06/23 31/03/23 30/12/22 -
Price 1.26 1.20 1.26 1.20 1.30 1.56 1.61 -
P/RPS 5.55 5.98 7.24 6.82 7.43 7.41 10.09 -32.89%
P/EPS 72.63 75.56 142.56 128.69 99.28 65.63 89.34 -12.90%
EY 1.38 1.32 0.70 0.78 1.01 1.52 1.12 14.94%
DY 0.79 0.00 1.43 0.00 0.38 0.00 1.12 -20.77%
P/NAPS 1.75 1.69 1.77 1.71 1.86 2.23 2.33 -17.38%
Price Multiplier on Announcement Date
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Date 15/08/24 23/05/24 22/02/24 08/11/23 24/08/23 22/05/23 23/02/23 -
Price 1.17 1.26 1.21 1.22 1.19 1.44 1.65 -
P/RPS 5.16 6.28 6.95 6.93 6.80 6.84 10.34 -37.11%
P/EPS 67.44 79.34 136.90 130.83 90.88 60.59 91.56 -18.45%
EY 1.48 1.26 0.73 0.76 1.10 1.65 1.09 22.64%
DY 0.85 0.00 1.49 0.00 0.42 0.00 1.09 -15.29%
P/NAPS 1.62 1.77 1.70 1.74 1.70 2.06 2.39 -22.85%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment